The elastin peptide VGVAPG increases CD4


Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
13 Jan 2021
Historique:
received: 24 09 2020
accepted: 22 12 2020
entrez: 13 1 2021
pubmed: 14 1 2021
medline: 9 10 2021
Statut: epublish

Résumé

In chronic obstructive pulmonary disease (COPD), lung-infiltrating inflammatory cells secrete proteases and participate in elastin breakdown and genesis of elastin-derived peptides (EP). In the present study, we hypothesized that the pattern of T lymphocytes cytokine expression may be modulated by EP in COPD patients. CD4 Compared with control, the percentage of IL-4 (Th2) producing CD4 The present study demonstrates that the VGVAPG elastin peptide modulates CD4

Sections du résumé

BACKGROUND BACKGROUND
In chronic obstructive pulmonary disease (COPD), lung-infiltrating inflammatory cells secrete proteases and participate in elastin breakdown and genesis of elastin-derived peptides (EP). In the present study, we hypothesized that the pattern of T lymphocytes cytokine expression may be modulated by EP in COPD patients.
METHODS METHODS
CD4
RESULTS RESULTS
Compared with control, the percentage of IL-4 (Th2) producing CD4
CONCLUSIONS CONCLUSIONS
The present study demonstrates that the VGVAPG elastin peptide modulates CD4

Identifiants

pubmed: 33435988
doi: 10.1186/s12931-020-01609-4
pii: 10.1186/s12931-020-01609-4
pmc: PMC7805078
doi:

Substances chimiques

IL4 protein, human 0
Oligopeptides 0
Interleukin-4 207137-56-2
valyl-glycyl-valyl-alanyl-prolyl-glycine 92899-39-3

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14

Références

Am J Physiol Lung Cell Mol Physiol. 2017 Sep 1;313(3):L534-L547
pubmed: 28572155
Respir Med. 2011 Nov;105(11):1648-54
pubmed: 21763119
PLoS Med. 2004 Oct;1(1):e8
pubmed: 15526056
Immunol Lett. 2008 Nov 16;121(1):13-21
pubmed: 18706444
Chest. 2008 Sep;134(3):483-488
pubmed: 18490406
N Engl J Med. 2004 Jun 24;350(26):2645-53
pubmed: 15215480
PLoS One. 2014 Jul 31;9(7):e103840
pubmed: 25078269
Clin Exp Immunol. 2009 Aug;157(2):316-24
pubmed: 19604272
Am J Respir Crit Care Med. 1996 Nov;154(5):1290-5
pubmed: 8912738
Am J Physiol Lung Cell Mol Physiol. 2006 Oct;291(4):L566-71
pubmed: 16698854
Thorax. 2013 May;68(5):421-8
pubmed: 23359459
Scand J Immunol. 2018 Jul;88(1):e12674
pubmed: 29752829
J Clin Invest. 2006 Mar;116(3):753-9
pubmed: 16470245
Clin Immunol. 2015 Dec;161(2):150-5
pubmed: 26220216
J Allergy Clin Immunol. 2016 Jul;138(1):16-27
pubmed: 27373322
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):822-6
pubmed: 9517597
Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1353-8
pubmed: 15860743
Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):762-6
pubmed: 1554198
Respir Res. 2011 Apr 10;12:43
pubmed: 21477350
Am J Physiol Lung Cell Mol Physiol. 2014 Oct 1;307(7):L557-65
pubmed: 25106431
PLoS One. 2014 Nov 06;9(11):e112350
pubmed: 25375131
J Immunol. 2007 Nov 1;179(9):6184-92
pubmed: 17947694
Lab Invest. 2002 Jan;82(1):79-85
pubmed: 11796828
Eur Respir J. 2004 Jul;24(1):78-85
pubmed: 15293608
Biochem Biophys Res Commun. 1997 Oct 9;239(1):146-9
pubmed: 9345285
Biochimie. 2006 Dec;88(12):1915-21
pubmed: 16945464
J Clin Invest. 1993 Mar;91(3):1198-205
pubmed: 8383699
Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):720-4
pubmed: 8810611
Am J Physiol Lung Cell Mol Physiol. 2015 Jan 15;308(2):L179-90
pubmed: 25416382
Am J Physiol Lung Cell Mol Physiol. 2016 Jan 1;310(1):L8-23
pubmed: 26519205
Respir Res. 2010 Jun 11;11:76
pubmed: 20540777
J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):458-62
pubmed: 10069880

Auteurs

Flora Lemaire (F)

Laboratory of Immunology, EA7509 IRMAIC, University of Reims Champagne-Ardenne (URCA), Reims, France.

Sandra Audonnet (S)

Flow Cytometry Platform URCACyt, URCA, Reims, France.

Jeanne-Marie Perotin (JM)

Department of Pulmonary Medicine, University Hospital of Reims, Reims, France.
INSERM U1250, URCA, Reims, France.

Pierre Gaudry (P)

Department of Pulmonary Medicine, University Hospital of Reims, Reims, France.

Sandra Dury (S)

Laboratory of Immunology, EA7509 IRMAIC, University of Reims Champagne-Ardenne (URCA), Reims, France.
Department of Pulmonary Medicine, University Hospital of Reims, Reims, France.

Julien Ancel (J)

Department of Pulmonary Medicine, University Hospital of Reims, Reims, France.

François Lebargy (F)

Laboratory of Immunology, EA7509 IRMAIC, University of Reims Champagne-Ardenne (URCA), Reims, France.
Department of Pulmonary Medicine, University Hospital of Reims, Reims, France.

Frank Antonicelli (F)

Laboratory of Immunology, EA7509 IRMAIC, University of Reims Champagne-Ardenne (URCA), Reims, France.

Gaëtan Deslée (G)

Department of Pulmonary Medicine, University Hospital of Reims, Reims, France.
INSERM U1250, URCA, Reims, France.

Richard Le Naour (R)

Laboratory of Immunology, EA7509 IRMAIC, University of Reims Champagne-Ardenne (URCA), Reims, France. richard.lenaour@univ-reims.fr.
Flow Cytometry Platform URCACyt, URCA, Reims, France. richard.lenaour@univ-reims.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH